Nalaganje...

Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity

To date, parathyroid hormone is the only clinically available bone anabolic drug. The major difficulty in the development of such drugs is the lack of clarification of the mechanisms regulating osteoblast differentiation and bone formation. Here, we report a peptide (W9) known to abrogate osteoclast...

Popoln opis

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Furuya, Yuriko, Inagaki, Atsushi, Khan, Masud, Mori, Kaoru, Penninger, Josef M., Nakamura, Midori, Udagawa, Nobuyuki, Aoki, Kazuhiro, Ohya, Keiichi, Uchida, Kohji, Yasuda, Hisataka
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Biochemistry and Molecular Biology 2013
Teme:	Cell Biology
Online dostop:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3581422/ https://ncbi.nlm.nih.gov/pubmed/23319583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M112.426080
Oznake:	Označite Brez oznak, prvi označite!

Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity

Podobne knjige/članki